- Home
- MYD vs NRC Comparison
MYD vs NRC Comparison
Compare MYD & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYD
- NRC
- Stock Information
- Founded
- MYD 1991
- NRC 1981
- Country
- MYD United States
- NRC United States
- Employees
- MYD N/A
- NRC N/A
- Industry
- MYD Investment Bankers/Brokers/Service
- NRC Biotechnology: Commercial Physical & Biological Resarch
- Sector
- MYD Finance
- NRC Health Care
- Exchange
- MYD Nasdaq
- NRC Nasdaq
- Market Cap
- MYD 460.1M
- NRC 394.2M
- IPO Year
- MYD N/A
- NRC N/A
- Fundamental
- Price
- MYD $10.33
- NRC $12.99
- Analyst Decision
- MYD
- NRC
- Analyst Count
- MYD 0
- NRC 0
- Target Price
- MYD N/A
- NRC N/A
- AVG Volume (30 Days)
- MYD 253.1K
- NRC 96.5K
- Earning Date
- MYD 01-01-0001
- NRC 04-28-2025
- Dividend Yield
- MYD 4.55%
- NRC 3.72%
- EPS Growth
- MYD N/A
- NRC N/A
- EPS
- MYD N/A
- NRC 1.02
- Revenue
- MYD N/A
- NRC $141,298,000.00
- Revenue This Year
- MYD N/A
- NRC N/A
- Revenue Next Year
- MYD N/A
- NRC N/A
- P/E Ratio
- MYD N/A
- NRC $13.16
- Revenue Growth
- MYD N/A
- NRC N/A
- 52 Week Low
- MYD $8.76
- NRC $9.76
- 52 Week High
- MYD $11.30
- NRC $35.81
- Technical
- Relative Strength Index (RSI)
- MYD 55.52
- NRC 57.23
- Support Level
- MYD $10.21
- NRC $12.39
- Resistance Level
- MYD $10.36
- NRC $13.29
- Average True Range (ATR)
- MYD 0.13
- NRC 0.72
- MACD
- MYD 0.05
- NRC 0.37
- Stochastic Oscillator
- MYD 95.52
- NRC 78.59
About MYD Blackrock MuniYield Fund Inc.
Blackrock Muniyield Fund Inc is a non-diversified, closed-end management investment company. The fund's objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes as is consistent with its investment policies and prudent investment management. The company invests in Transportation, Corporate, Health, Utilities, Education, Housing, and other sectors.
About NRC National Research Corporation (Delaware)
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.